International Companies

Roche confident despite strong Swiss franc, threat of generics

By Josh White

Date: Thursday 23 Apr 2026

(Sharecast News) - Roche reported a 5% fall in first-quarter sales to CHF 14.7bn (£13.88bn) on Thursday, as the strength of the Swiss franc and generic competition for older drugs weighed on reported results, though sales rose 6% at constant exchange rates and the company maintained its full-year outlook.
Chief executive...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page